Ann: Rhythm Establishes US Entity To Drive US Expansion Strategy, page-7

There is not too much to speculate about with ColoSTAT to be honest: if they manage to commercialise it then given its price, "accuracy" and convenience advantage then it should rapidly move into the niche currently filled by the faecal test. Simples!

If you want a contrast check out the Brainchip (BRN) threads which regularly produce the most popular hc posts of the day and which can have a couple of hundred posts a day. And all this as the share price continues to sag and there is no ASX reported news. That is what you get when the stock has 36,000 mums and dads shareholders and virtually no institutional interest. Like a bus-full of school kids off to the zoo. For sure, there could be some really good news coming for Brainchip in the next couple of months but that is similarly the case for Rhythm.

One area where I think they do need to start pushing more is what next for Rhythm? Assuming ColoSTAT is successfully commercialised what exactly is the next candidate in the pipeline and what are they doing to progress that next project?